Gary E. Stein
Impact in
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
Papers in ⓘ
- Pharmacology 48
- Antibiotics Pharmacokinetics and Efficacy 47
- Epidemiology 40
- Pneumonia and Respiratory Infections 17
- Urinary Tract Infections Management 13
- Co-authors
- Louis D. Saravolatz (5 shared papers)Timothy Babinchak (1 shared paper)Leonard B. Johnson (2 shared papers)Daniel Havlichek (15 shared papers)Elizabeth Wells (1 shared paper)David P. Nicolau (8 shared papers)Robert D. Walker (4 shared papers)Thomas M. File (2 shared papers)
- Journals
- Clinical Infectious Diseases (11 papers)Annals of Pharmacotherapy (8 papers)Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (7 papers)Antimicrobial Agents and Chemotherapy (5 papers)Diagnostic Microbiology and Infectious Disease (4 papers)
- Partner nations
- United StatesAustraliaSwitzerland
In The Last Decade
Gary E. Stein
81 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 126
- Molecular Medicine 743
- Applied Microbiology and Biotechnology 181
- Clinical Biochemistry 429
- Pharmacology 909
- Infectious Diseases 864
Countries citing papers authored by Gary E. Stein
This map shows the geographic impact of Gary E. Stein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary E. Stein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary E. Stein more than expected).
Fields of papers citing papers by Gary E. Stein
This network shows the impact of papers produced by Gary E. Stein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary E. Stein. The network helps show where Gary E. Stein may publish in the future.
Co-authors
The 25 scholars most cited alongside Gary E. Stein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 82 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 214 | |
| 2 | 1987 | 156 | |
| 3 | 2013 | 150 | |
| 4 | 2011 | 127 | |
| 5 | 2010 | 105 | |
| 6 | 1996 | 104 | |
| 7 | 1995 | 94 | |
| 8 | 1999 | 93 | |
| 9 | 2009 | 87 | |
| 10 | 2012 | 80 | |
| 11 | 1992 | 66 | |
| 12 | 2005 | 64 | |
| 13 | 2015 | 61 | |
| 14 | 2006 | 58 | |
| 15 | 2019 | 55 | |
| 16 | 1987 | 55 | |
| 17 | 2007 | 53 | |
| 18 | 2018 | 43 | |
| 19 | 1993 | 41 | |
| 20 | 2014 | 39 |
About Gary E. Stein
Gary E. Stein is a scholar working on Pharmacology, Epidemiology, Infectious Diseases, Molecular Medicine and Clinical Biochemistry, having authored 82 papers that have together received 2.6k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (47 papers), Antimicrobial Resistance in Staphylococcus (25 papers), Antibiotic Resistance in Bacteria (21 papers), Bacterial Identification and Susceptibility Testing (18 papers), Pneumonia and Respiratory Infections (17 papers), Urinary Tract Infections Management (13 papers), Reproductive tract infections research (9 papers) and Antifungal resistance and susceptibility (6 papers). The work is most often cited by research in Molecular Medicine (743 citations), Applied Microbiology and Biotechnology (181 citations), Clinical Biochemistry (429 citations), Pharmacology (909 citations) and Infectious Diseases (864 citations). Gary E. Stein has collaborated with scholars based in United States, Australia and Switzerland. Frequent co-authors include Louis D. Saravolatz, Timothy Babinchak, Leonard B. Johnson, Daniel Havlichek, Elizabeth Wells, David P. Nicolau, Robert D. Walker, Thomas M. File, E. J. C. Goldstein and J. G. Hauptman. Their work appears in journals such as Clinical Infectious Diseases, Annals of Pharmacotherapy, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, Antimicrobial Agents and Chemotherapy and Diagnostic Microbiology and Infectious Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.